Benlong Yang

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Current practices and trends of axillary surgery de-escalation and lymphedema management for breast cancer in China: a nationwide cross-sectional survey.

Current practices and trends of axillary surgery de-escalation and lymphedema management for breast cancer in China: a nationwide cross-sectional survey.

Journal: World journal of surgical oncology

Published: March 30, 2026

Current landscape and challenges in autologous breast reconstruction across China: A nationwide questionnaire-based survey of 198 hospitals.

Current landscape and challenges in autologous breast reconstruction across China: A nationwide questionnaire-based survey of 198 hospitals.

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Published: August 09, 2025

Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey.

Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey.

Journal: Aesthetic plastic surgery

Published: June 13, 2025

Current practices and trends of breast-conserving surgery in China: A nationwide cross-sectional survey.

Current practices and trends of breast-conserving surgery in China: A nationwide cross-sectional survey.

Journal: Chinese medical journal

Published: May 08, 2025

Current Practices and Evolving Trends in Implant-based Breast Reconstruction in China: A Nationwide Cross-sectional Survey.

Current Practices and Evolving Trends in Implant-based Breast Reconstruction in China: A Nationwide Cross-sectional Survey.

Journal: Plastic and reconstructive surgery. Global open

Published: April 18, 2025

A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.

A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.

Journal: International journal of surgery (London, England)

Published: April 09, 2025

Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China.

Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China.

Journal: BMC cancer

Published: November 08, 2024

Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey.

Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 14, 2024

Implementation and development of endoscopic benign breast lump resection and breast-conserving surgery for cancer

Implementation and development of endoscopic benign breast lump resection and breast-conserving surgery for cancer

Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery

Published: July 16, 2024

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

Journal: EClinicalMedicine

Published: April 17, 2024

Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes.

Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes.

Journal: Cancer treatment reviews

Published: February 29, 2024

CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration.

CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration.

Journal: International immunopharmacology

Published: November 07, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026